Publications Office of the EU
Affaire T-175/22: Recours introduit le 4 avril 2022 — Novartis/EUIPO — AstraZeneca (BREZTRI)
DisplayCustomHeader
Webcontent weergeven
Publication Detail Actions Portlet
custom-survey-notification
Publication Detail Portlet

Publication detail

Home
Publication Viewer

Documentviewer

Pop up window annotations